Immune-mediated activation of the endocannabinoid system in visceral adipose tissue in obesity

被引:44
作者
Kempf, K.
Hector, J.
Strate, T.
Schwarzloh, B.
Rose, B.
Herder, C.
Martin, S.
Algenstaedt, P.
机构
[1] Univ Dusseldorf, Leibniz Inst, German Diabet Ctr, Inst Clin Diabet Res, D-40225 Dusseldorf, Germany
[2] Univ Hamburg, Dept Internal Med, Hamburg, Germany
[3] Univ Hamburg, Dept Surg, Hamburg, Germany
关键词
endocannabinoid system; inflammation; obesity; adipose tissue; cytokines;
D O I
10.1055/s-2007-984459
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the study was to investigate if the endocannabinoid system (ECS) is activated in visceral adipose tissue and if adipose tissue inflammation affects the ECS activation state. Therefore, expression of fatty acid amide hydrolase (FAAH), cannabinoid receptor 1 (Cb1), adiponectin, and tumor necrosis factor (TNF)-alpha was compared in visceral adipose tissue from 10 normal-weight (BMI 24.4 +/- 1.1 kg/m(2)) and I I obese subjects (BMI 37.6 +/- 13.6 kg/m(2)) using quantitative RT-PCR, and gene expression changes were analyzed after in vitro stimulation of visceral adipose tissue with TNF-alpha. The data demonstrate that the ECS is activated in obese visceral adipose tissue as shown by decreased FAAH, Cb1, and adiponectin expression. Obesity-related ECS activation is accompanied by elevated expression of the pro-inflammatory cytokine TNF-alpha, which in turn stimulates ECS activation in vitro. Our data show a strong association between adipose tissue inflammation and ECS activation in obesity, and indicate that a pro-inflammatory state may directly activate the ECS.
引用
收藏
页码:596 / 600
页数:5
相关论文
共 37 条
[1]   Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83
[2]   The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells [J].
Bensaid, M ;
Gary-Bobo, M ;
Esclangon, A ;
Maffrand, JP ;
Le Fur, G ;
Oury-Donat, F ;
Soubrié, P .
MOLECULAR PHARMACOLOGY, 2003, 63 (04) :908-914
[3]   Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity [J].
Blueher, Matthias ;
Engeli, Stefan ;
Kloeting, Nora ;
Berndt, Janin ;
Fasshauer, Mathias ;
Batkai, Sandor ;
Pacher, Pal ;
Schoen, Michael R. ;
Jordan, Jens ;
Stumvoll, Michael .
DIABETES, 2006, 55 (11) :3053-3060
[4]   Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity [J].
Cancello, Raffaella ;
Tordjman, Joan ;
Poitou, Christine ;
Guilhem, Gael ;
Bouillot, Jean Luc ;
Hugol, Danielle ;
Coussieu, Christiane ;
Basdevant, Arnaud ;
Bar Hen, Avner ;
Bedossa, Pierre ;
Guerre-Millo, Michele ;
Clement, Karine .
DIABETES, 2006, 55 (06) :1554-1561
[5]   Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve [J].
Costa, B ;
Trovato, AE ;
Colleoni, M ;
Giagnoni, G ;
Zarini, E ;
Croci, T .
PAIN, 2005, 116 (1-2) :52-61
[6]  
Cota D, 2003, J CLIN INVEST, V112, P423, DOI [10.1172/JCI200317725, 10.1172/JCI17725]
[7]   Role of cannabinoid CB1 receptors and tumor necrosis factor-α in the gut and systemic anti-inflammatory activity of SR 141716 (Rimonabant) in rodents [J].
Croci, T ;
Landi, M ;
Galzin, AM ;
Marini, P .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (01) :115-122
[8]   From blood monocytes to adipose tissue-resident macrophages -: Induction of diapedesis by human mature adipocytes [J].
Curat, CA ;
Miranville, A ;
Sengenès, C ;
Diehl, M ;
Tonus, C ;
Busse, R ;
Bouloumié, A .
DIABETES, 2004, 53 (05) :1285-1292
[9]   Induction of interleukin-2 receptor alpha gene by Delta(9)-tetrahydrocannabinol is mediated by nuclear factor kappa B and CB1 cannabinoid receptor [J].
Daaka, Y ;
Zhu, WG ;
Friedman, H ;
Klein, TW .
DNA AND CELL BIOLOGY, 1997, 16 (03) :301-309
[10]   Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia [J].
Despres, JP ;
Golay, A ;
Sjostrom, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2121-2134